Cannabidiol (CBD) and its analogs: a review of their effects on inflammation.

@article{Burstein2015CannabidiolA,
  title={Cannabidiol (CBD) and its analogs: a review of their effects on inflammation.},
  author={S. Burstein},
  journal={Bioorganic & medicinal chemistry},
  year={2015},
  volume={23 7},
  pages={
          1377-85
        }
}
  • S. Burstein
  • Published 2015
  • Chemistry, Medicine
  • Bioorganic & medicinal chemistry
First isolated from Cannabis in 1940 by Roger Adams, the structure of CBD was not completely elucidated until 1963. Subsequent studies resulted in the pronouncement that THC was the 'active' principle of Cannabis and research then focused primarily on it to the virtual exclusion of CBD. This was no doubt due to the belief that activity meant psychoactivity that was shown by THC and not by CBD. In retrospect this must be seen as unfortunate since a number of actions of CBD with potential… Expand
194 Citations
Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy
  • 93
  • PDF
Pharmacology and legal status of cannabidiol.
  • 3
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies
  • 149
  • PDF
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 66 REFERENCES
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action.
  • A. Zuardi
  • Psychology, Medicine
  • Revista brasileira de psiquiatria
  • 2008
  • 298
  • PDF
The cannabinoid acids: nonpsychoactive derivatives with therapeutic potential.
  • S. Burstein
  • Chemistry, Biology
  • Pharmacology & therapeutics
  • 1999
  • 88
  • PDF
Phytocannabinoids as novel therapeutic agents in CNS disorders.
  • 206
  • PDF
Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL‐2H3 mast cells
  • 35
Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview
  • 58
  • PDF
Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity.
  • 29
...
1
2
3
4
5
...